Global Diagnostic Initiatives FIND’s extensive collaborations with WHO, Ministry of Health, MSF, and other international organizations position it as a key partner in deploying diagnostic solutions in emerging and conflict-affected regions, creating opportunities to supply specialized testing equipment and support services.

Innovation in Rare Diseases The company’s focus on novel diagnostic programs like Seq&Treat for DR-TB and hepatitis C self-testing presents a niche market for advanced sequencing technology, point-of-care testing, and streamlined diagnostic processes tailored for high-need disease areas.

Expanding Market Footprint With regional hubs in Africa and Asia, FIND is well-positioned to expand its reach into developing markets requiring cost-effective, scalable testing solutions, opening avenues for technology partnerships and localized diagnostic product offerings.

Partnership-Driven Revenue FIND’s strategic alliances with private companies such as Pluslife and Kountable indicate potential for collaborative opportunities in diagnostic device distribution, procurement services, and expanding access to underserved populations through joint ventures.

Funding and Growth Potential Backed by substantial revenue in the billion-dollar range and ongoing major global health initiatives, the company presents opportunities for high-value, large-scale sales of diagnostic platforms, reagents, and ongoing support contracts aligned with its mission to improve access worldwide.